AdaptHealth’s (AHCO) Sell (D+) Rating Reiterated at Weiss Ratings

Weiss Ratings reaffirmed their sell (d+) rating on shares of AdaptHealth (NASDAQ:AHCO) in a research note released on Wednesday morning,Weiss Ratings reports.

AHCO has been the topic of a number of other reports. Zacks Research downgraded shares of AdaptHealth from a “hold” rating to a “strong sell” rating in a research note on Friday, September 19th. Wall Street Zen raised shares of AdaptHealth from a “buy” rating to a “strong-buy” rating in a research note on Friday, October 3rd. Five investment analysts have rated the stock with a Buy rating and two have assigned a Sell rating to the company. According to MarketBeat.com, AdaptHealth presently has a consensus rating of “Hold” and an average target price of $13.40.

AdaptHealth Price Performance

Shares of AHCO stock opened at $8.70 on Wednesday. The company has a debt-to-equity ratio of 1.14, a current ratio of 1.06 and a quick ratio of 0.82. The firm’s 50-day moving average is $9.23 and its two-hundred day moving average is $9.08. AdaptHealth has a 12 month low of $7.11 and a 12 month high of $11.63. The company has a market capitalization of $1.18 billion, a PE ratio of 16.11, a price-to-earnings-growth ratio of 1.10 and a beta of 1.61.

Insider Buying and Selling at AdaptHealth

In other AdaptHealth news, Director David Solomon Williams III sold 8,200 shares of AdaptHealth stock in a transaction dated Friday, August 22nd. The shares were sold at an average price of $9.73, for a total transaction of $79,786.00. Following the completion of the sale, the director directly owned 50,045 shares in the company, valued at $486,937.85. This trade represents a 14.08% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.55% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On AdaptHealth

A number of institutional investors have recently made changes to their positions in the stock. SummerHaven Investment Management LLC increased its position in shares of AdaptHealth by 1.7% during the first quarter. SummerHaven Investment Management LLC now owns 79,883 shares of the company’s stock valued at $866,000 after acquiring an additional 1,329 shares during the last quarter. Janney Montgomery Scott LLC increased its position in shares of AdaptHealth by 1.9% during the second quarter. Janney Montgomery Scott LLC now owns 80,301 shares of the company’s stock valued at $757,000 after acquiring an additional 1,511 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS grew its holdings in shares of AdaptHealth by 6.6% in the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 27,095 shares of the company’s stock valued at $256,000 after purchasing an additional 1,671 shares in the last quarter. Oppenheimer Asset Management Inc. grew its holdings in shares of AdaptHealth by 6.8% in the first quarter. Oppenheimer Asset Management Inc. now owns 32,797 shares of the company’s stock valued at $356,000 after purchasing an additional 2,081 shares in the last quarter. Finally, State of Alaska Department of Revenue grew its holdings in shares of AdaptHealth by 4.0% in the second quarter. State of Alaska Department of Revenue now owns 62,807 shares of the company’s stock valued at $592,000 after purchasing an additional 2,418 shares in the last quarter. 82.67% of the stock is currently owned by institutional investors and hedge funds.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.